Chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) receptor 2 autocrine loop contributes to cellular proliferation, migration and apoptosis in cervical cancer

References

• Aalijahan H, Ghorbian S. Long non-coding RNAs and cervical cancer. Exp Mol Pathol. 2019;106:7–16.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
   PubMed Web of Science ®Google Scholar
• Chen X, Leung SY, Yuen ST, et al. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell. 2003;14(8):3208–3215.
   PubMed Web of Science ®Google Scholar
• Siva S, Herschtal A, Thomas JM, et al. Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer. Cancer. 2011;117(17):3981–3988.
   PubMed Web of Science ®Google Scholar
• Cooke SL, Temple J, MacArthur S, et al. Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer. Br J Cancer. 2011;104(2):361–368.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kim YS, Shin SS, et al. Long-term outcomes of concomitant chemoradiotherapy incorporating high-dose-rate brachytherapy to treat locally advanced cervical cancer. Tumori. 2012;98(5):615–621.
   PubMed Web of Science ®Google Scholar
• Haskill S, Peace A, Morris J, et al. Identification of three related human GRO genes encoding cytokine functions. Proc Natl Acad Sci U S A. 1990;87(19):7732–7736.
   PubMed Web of Science ®Google Scholar
• Wen Y, Giardina SF, Hamming D, et al. GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1. Clin Cancer Res. 2006;12(20 Pt 1):5951–5959.
   PubMed Web of Science ®Google Scholar
• Miyake M, Lawton A, Goodison S, et al. Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers. BMC Cancer. 2013;13:322.
   PubMed Web of Science ®Google Scholar
• Oladipo O, Conlon S, O’Grady A, et al. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue. Br J Cancer. 2011;104(3):480–487.
   PubMed Web of Science ®Google Scholar
• Richmond A, Thomas HG. Melanoma growth stimulatory activity: isolation from human melanoma tumors and characterization of tissue distribution. J Cell Biochem. 1988;36(2):185–198.
   PubMed Web of Science ®Google Scholar
• Anisowicz A, Bardwell L, Sager R. Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells. Proc Natl Acad Sci U S A. 1987;84(20):7188–7192.
   PubMed Web of Science ®Google Scholar
• Vries MH, Wagenaar A, Verbruggen SEL, et al. CXCL1 promotes arteriogenesis through enhanced monocyte recruitment into the peri-collateral space. Angiogenesis. 2015;18(2):163–171.
   PubMed Web of Science ®Google Scholar
• Devalaraja RM, Nanney LB, Du J, et al. Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol. 2000;115(2):234–244.
   PubMed Web of Science ®Google Scholar
• Owen JD, Strieter R, Burdick M, et al. Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins. Int J Cancer. 1997;73(1):94–103.
   PubMed Web of Science ®Google Scholar
• Tsai HH, Frost E, To V, et al. The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell. 2002;110(3):373–383.
   PubMed Web of Science ®Google Scholar
• Loukinova E, Dong G, Enamorado-Ayalya I, et al. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene. 2000;19(31):3477–3486.
   PubMed Web of Science ®Google Scholar
• Peng W, Ye Y, Rabinovich BA, et al. Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses. Clin Cancer Res. 2010;16(22):5458–5468.
   PubMed Web of Science ®Google Scholar
• Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–678.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.
   PubMed Web of Science ®Google Scholar
• Yu GC, Wang L-G, Han YY, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287.
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(25):1937–1947.
   PubMed Web of Science ®Google Scholar
• Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56(2):337–344.
   PubMed Web of Science ®Google Scholar
• Reimand J, Isserlin R, Voisin V, et al. Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nat Protoc. 2019;14(2):482–517.
   PubMed Web of Science ®Google Scholar
• Fan YR, Sheng WW, Meng Y, et al. LncRNA PTENP1 inhibits cervical cancer progression by suppressing miR-106b. Artif Cells Nanomed Biotechnol. 2020;48(1):393–407.
   PubMed Web of Science ®Google Scholar
• Jiao X, Zhang SY, Jiao J, et al. Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance. Clin Epigenetics. 2019;11(1):120.
   PubMed Web of Science ®Google Scholar
• Wu A, Lin L, Li X, et al. Overexpression of ARHGAP30 suppresses growth of cervical cancer cells by downregulating ribosome biogenesis. Cancer Sci. 2021;112(11):4515–4525.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li L, Liu Y, et al. RECK inhibits cervical cancer cell migration and invasion by promoting p53 signaling pathway. J Cell Biochem. 2018;119(4):3058–3066.
   PubMed Web of Science ®Google Scholar
• Wang XZ, Jia Z, Yang HH, et al. Dibenzoxanthenes induce apoptosis and autophagy in HeLa cells by modeling the PI3K/Akt pathway. J Photochem Photobiol B. 2018;187:76–88.
   PubMed Web of Science ®Google Scholar
• Stadler C, Rexhepaj E, Singan VR, et al. Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells. Nat Methods. 2013;10(4):315–323.
   PubMed Web of Science ®Google Scholar
• Wang N, Liu W, Zheng Y, et al. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-kappaB/SOX4 signaling. Cell Death Dis. 2018;9(9):880.
   PubMed Web of Science ®Google Scholar
• Wang D, Sun H, Wei J, et al. CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer. Cancer Res. 2017;77(13):3655–3665.
   PubMed Web of Science ®Google Scholar
• Yang C, Yu H, Chen R, et al. CXCL1 stimulates migration and invasion in ERnegative breast cancer cells via activation of the ERK/MMP2/9 signaling axis. Int J Oncol. 2019;55(3):684–696.
   PubMed Web of Science ®Google Scholar
• Luan J, Shattuck-Brandt R, Haghnegahdar H, et al. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leukoc Biol. 1997;62(5):588–597.
   PubMed Web of Science ®Google Scholar
• Richmond A, Thomas HG. Purification of melanoma growth stimulatory activity. J Cell Physiol. 1986;129(3):375–384.
   PubMed Web of Science ®Google Scholar
• White JR, Lee JM, Young PR, et al. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem. 1998;273(17):10095–10098.
   PubMed Web of Science ®Google Scholar
• Catusse J, Liotard A, Loillier B, et al. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2. Biochem Pharmacol. 2003;65(5):813–821.
   PubMed Web of Science ®Google Scholar
• Basu P, Mittal S, Bhadra Vale D, et al. Secondary prevention of cervical cancer. Best Pract Res Clin Obstet Gynaecol. 2018;47:73–85.
   PubMed Web of Science ®Google Scholar
• Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–19.
   PubMed Web of Science ®Google Scholar
• Nishikawa R, Suzumori N, Nishiyama T, et al. Clinical significance of serum growth-regulated oncogene alpha (GROalpha) in patients with gynecological cancer. Eur J Gynaecol Oncol. 2012;33(2):138–141.
   PubMed Web of Science ®Google Scholar
• Zhi W, Ferris D, Sharma A, et al. Twelve serum proteins progressively increase with disease stage in squamous cell cervical cancer patients. Int J Gynecol Cancer. 2014;24(6):1085–1092.
   PubMed Web of Science ®Google Scholar